Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
SAMe wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
8 of 15 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
0 of 2 studies with measurable effects showed benefit.
Top outcomes
500-2000mg daily for lipid effects; 50-500mg for general health
With food (reduces flush), Evening for lipid effects, Split doses for high amounts
Immediate-release niacin (nicotinic acid)
400-1600mg for mood; 600-1200mg for joints
On empty stomach, Morning and/or midday
Enteric-coated tablets (SAMe tosylate or butanedisulfonate)
4-8 weeks
4-8 weeks
30-60 minutes after dose
2-6 weeks
4-8 weeks
4-8 weeks
Niacin for primary and secondary prevention of cardiovascular events
The Cochrane database of systematic reviews (2017) · Meta analysis · n=39195
Participants randomised to niacin were more likely to discontinue treatment due to side effects than participants randomised to control group (RR 2.17, 95% CI 1.70 to 2.77; participants = 33,539; studies = 17; I2 = 77%; moderate-quality evidence).
Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials
Atherosclerosis (2025) · Meta analysis · n=145314
Among available LLTs, PCSK9mAbs, inclisiran, CETPi, and niacin significantly decreased Lp(a) levels.
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Nature medicine (2024) · Meta analysis
Lastly, treatment with physiological levels of 4PY, but not its structural isomer 2PY, induced expression of VCAM-1 and leukocyte adherence to vascular endothelium in mice.
S-Adenosylmethionine for osteoarthritis of the knee or hip
The Cochrane database of systematic reviews (2009) · Meta analysis · n=656
For pain, the analysis indicated a small SMD of -0.17 (95% CI -0.34 to 0.01), corresponding to a difference in pain scores between SAMe and placebo of 0.4 cm on a 10 cm VAS, with no between trial heterogeneity (I(2) = 0).
Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta-Analysis
Neuropsychopharmacology reports (2025) · Meta analysis · n=1049
A meta-analysis found no significant difference in response rates between the two treatments (risk ratio [RR] = 0.96, 95% CI: 0.78-1.18) or dropout rates (RR = 1.08, 95% CI: 0.62-1.88).
S-Adenosylmethionine (SAMe) for Liver Health: A Systematic Review
Nutrients (2024) · Systematic review · n=15
The most common doses were SAMe 1000 mg or 1200 mg per day with or without another treatment or natural supplement.
Based on multiple meta-analyses showing HDL increases. Higher doses increase discontinuation rates due to side effects (RR 2.17). Immediate-release forms have better lipid effects but more flushing.
Meta-analysis of 656 patients showed small effect size (SMD -0.17) corresponding to only 0.4cm improvement on 10cm pain scale. Effect is modest and barely reaches statistical significance threshold.
AI-estimated from published studies. Interpret as directional guidance.
SAMe has a higher evidence score (9/10 vs 9/10) and wins in 1 of 3 categories.
For support mood, SAMe has a higher relevance score (90 vs 45).
No known interactions between Niacin and SAMe have been documented in our database. However, always consult a healthcare provider before combining supplements.